D
David S. Zuzga
Researcher at La Salle University
Publications - 16
Citations - 2117
David S. Zuzga is an academic researcher from La Salle University. The author has contributed to research in topics: Colorectal cancer & Vasodilator-stimulated phosphoprotein. The author has an hindex of 10, co-authored 16 publications receiving 1968 citations. Previous affiliations of David S. Zuzga include Thomas Jefferson University.
Papers
More filters
Journal ArticleDOI
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
Matthew J. During,Lei Cao,David S. Zuzga,Jeremy S. Francis,Helen L. Fitzsimons,Xiangyang Jiao,Ross J. Bland,Matthias Klugmann,William A. Banks,Daniel J. Drucker,Colin N. Haile +10 more
TL;DR: Systemic administration of [Ser(2)]exendin(1–9) in wild-type animals prevents kainate-induced apoptosis of hippocampal neurons and represents a promising new target for both cognitive-enhancing and neuroprotective agents.
Journal ArticleDOI
VEGF links hippocampal activity with neurogenesis, learning and memory.
Lei Cao,Xiangyang Jiao,David S. Zuzga,Yuhong Liu,Dahna M. Fong,Deborah Young,Matthew J. During,Matthew J. During,Matthew J. During +8 more
TL;DR: It is shown that hippocampal expression of vascular endothelial growth factor (VEGF) is increased by both an enriched environment and performance in a spatial maze, supporting a model in which VEGF, acting through KDR, mediates the effect of the environment on neurogenesis and cognition.
Journal ArticleDOI
Subthalamic GAD gene therapy in a Parkinson's disease rat model.
Jia Luo,Michael G. Kaplitt,Helen L. Fitzsimons,David S. Zuzga,Yuhong Liu,Michael L. Oshinsky,Matthew J. During +6 more
TL;DR: Using adeno-associated viral vector–mediated somatic cell gene transfer, glutamic acid decarboxylase (GAD), the enzyme that catalyzes synthesis of the neurotransmitter GABA, is expressed in excitatory glutamatergic neurons of the STN in rats, resulting in strong neuroprotection of nigral dopamine neurons and rescue of the parkinsonian behavioral phenotype.
Journal ArticleDOI
Tumor Epithelial Cell Matrix Metalloproteinase 9 Is a Target for Antimetastatic Therapy in Colorectal Cancer
Wilhelm J. Lubbe,Zengyi Y. Zhou,Weili Fu,David S. Zuzga,Stephanie Schulz,Rafael Fridman,Ruth J. Muschel,Scott A. Waldman,Giovanni Pitari +8 more
TL;DR: Observations reveal that MMP-9 produced by human colon cancer, rather than stromal, cells is central to processes underlying metastasis and underscores the previously unrecognized potential of specifically targeting tumor cell M MP-9 in interventional strategies to reduce mortality from metastatic colorectal cancer.
Journal ArticleDOI
The paracrine hormone hypothesis of colorectal cancer.
Giovanni Pitari,Peng Li,Jun-Hsiang Lin,David S. Zuzga,Ahmara Vivian Gibbons,Adam E. Snook,Stephanie Schulz,Scott A. Waldman +7 more
TL;DR: In the intestine, guanylyl cyclase C and its paracrine ligands organize and regulate the homeostatic integrity of the crypt–villus axis, forming a hormonal tumor suppressor signaling sequence, whose dysfunction defines the initiation of neoplastic transformation and creates a permissive niche for tumor progression.